Disatorn Dejvajara

Ms. Disatorn Dejvajara

Chiang Mai University, Chiang Mai, Thailand
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2025 in Hepatology
Verified
Journal Article
Closed access
PDPojsakorn Danpanichkul
Pojsakorn Danpanichkul
KDKwanjit Duangsonk
Kwanjit Duangsonk
VCVincent Chen
Vincent Chen
PSPreenapun Saokhieo
Preenapun Saokhieo
DDDisatorn Dejvajara
Disatorn Dejvajara
KWKarn Wijarnpreecha
Karn Wijarnpreecha
Backgrounds &Aims: Hepatitis B virus (HBV)-related liver disease ranks as the seventh leading cause of mortality. Despite advances in prevention and treatment, global disparities in the burden of primary liver cancer (PLC) persist. We evaluate global trends in the prevalence, incidence, and death of HBV-related liver disease. Approach and Results: Data from the Global Burden of Disease Study 2021 evaluated acute HBV infection, HBV-related cirrhosis, and HBV-related liver cancer prevalence, incidence, and death. In 2021, there were 7.30 million cases of acute HBV, 283.64 million cases of HBV-related cirrhosis, and 288,110 cases of HBV-related PLC. HBV-related PLC accounted for 39% of the global incidence of PLC; Western Pacific had the highest rates for HBV-related PLC, with an incidence of 5.24 and a death rate of 4.38 per 100,000 population. Between 2000-2021, age-standardized incidence, prevalence, and death rates from HBV-related liver disease decreased; however, the incidence of HBV-related PLC rose in 65 countries from 2000 to 2021. In parallel, age-standardized prevalent rates from HBV-related PLC increased in Europe (Annual percent change [APC]: 0.77%, 95% confidence interval [CI] 0.72 to 0.81%) and the Americas (APC: 1.05%, 95%CI 1.00 to 1.10%). Conclusion: From 2000 to 2021, decreases in HBV-related liver disease incidence and prevalence were observed; however, more than one-third of countries showed an increase in the incidence of HBV-related PLC. These findings highlight the need for strengthened HBV treatment efforts to reduce the risk of liver cancer. Export

26 January 2024 in JHEP Reports
Verified
Journal Article
Open access
PDPojsakorn Danpanichkul
Pojsakorn Danpanichkul
KSKanokphong Suparan
Kanokphong Suparan
CNCheng Han Ng
Cheng Han Ng
DDDisatorn Dejvajara
Disatorn Dejvajara
SKSiwanart Kongarin
Siwanart Kongarin
KWKarn Wijarnpreecha
Karn Wijarnpreecha
Alcohol-associated liver diseases (ALDs) and alcohol use disorder (AUD) pose a global health risk. AUD is underrecognized in the elderly, and the burden of AUD complications, including ALD, may increase with aging populations and rising alcohol intake. However, there is a lack of epidemiological evidence on AUD and ALD in the elderly. Using the Global Burden of Disease Study 2019, we analyzed the prevalence, mortality, disability-adjusted life years (DALYs), age-standardized rates (ASRs), and temporal change from 2000 to 2019 of ALD and AUD in the overall population and the elderly (65–89 years). The findings were categorized by sex, region, nation, and sociodemographic index. The prevalence rates of ALD in the elderly were higher than those in adolescents and young adults, whereas AUD levels were lower than those in adolescents and young adults. In 2019, there were 9.39 million cases (8.69% of cases in the overall population) of AUD, 3.23 million cases (21.8% of cases in the overall population) of alcohol-associated cirrhosis, and 68,468 cases (51.27% of cases in the overall population) of liver cancer from alcohol among the elderly. ASRs of the prevalence of ALD and AUD in the elderly increased in most regions; on the contrary, ASRs of death and DALYs decreased in most regions. Nevertheless, ASRs of death and DALYs from liver cancer from alcohol increased in many areas. Our findings highlighted the increased prevalence of ALD in the elderly, with a burden of AUD comparable with that in the overall population. Public health strategies on ALD and AUD targeting the elderly are urgently needed. The burden of alcohol-associated liver disease (ALD) and alcohol use disorder (AUD) is increasing. Advances in healthcare and education have resulted in a remarkable spike in life expectancy and a consequential population aging. Nevertheless, little is known about the epidemiology of ALD and AUD in the elderly. Our study indicates the increasing burden of ALD and AUD in the elderly population, necessitating early detection, intervention, and tailored care to the unique needs and complexities faced by older individuals grappling with these conditions.

18 October 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PDPojsakorn Danpanichkul
Pojsakorn Danpanichkul
KDKwanjit Duangsonk
Kwanjit Duangsonk
AHAgnes H.Y. Ho
Agnes H.Y. Ho
PLPassisd Laoveeravat
Passisd Laoveeravat
CVChawinthorn Vuthithammee
Chawinthorn Vuthithammee
KWKarn Wijarnpreecha
Karn Wijarnpreecha
INTRODUCTION: To update the global burden of inflammatory bowel disease (IBD) using data from the Global Burden of Disease 2021. METHODS: Data from Global Burden of Disease 2021 were analyzed to assess the IBD burden. RESULTS: In 2021, there were 375,140 new cases and 3.83 million total cases of IBD. Elderly onset IBD accounted for 11% of incidences. 167 countries increased IBD incidence rate, with rates rising in female patients (APC: +0.06%) and the elderly (APC: +0.14%) but stable in male patients and the overall population. DISCUSSION: Although the global burden of IBD has decreased overall, it has increased in female patients and the elderly.

11 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
PDPojsakorn Danpanichkul
Pojsakorn Danpanichkul
YPYanfang Pang
Yanfang Pang
LDLuis Antonio Diaz
Luis Antonio Diaz
JAJuan Pablo Arab
Juan Pablo Arab
SHSoo Young Hwang
Soo Young Hwang
JYJudong Yang
Judong Yang
Background/Objectives: The incidence and mortality of early-onset cancers have been rising in recent decades. While epidemiological studies have examined various types of cancer, updated global data on alcohol-attributable primary liver cancer (PLC) in young adults remains limited. Methods: This study utilized data from the Global Burden of Disease (GBD) study spanning 2000 to 2021 to evaluate the age-standardized incidence, mortality, and corresponding rates of alcohol-attributable PLC among young adults aged 15–49 years. Results: In 2021, there were 8290 incidence cases and 6590 deaths from alcohol-attributable PLC in young adults. The age-standardized incidence rate has increased in Europe (annual percent change [APC]: 0.44%, 95%CI 0.35 to 0.54%), Southeast Asia (APC: 0.40%, 95% CI 0.37 to 0.44%), and the Western Pacific region (APC: 0.65%, 95% CI 0.44 to 0.86%). In 2021, alcohol-attributable PLC in young adults represented 11% (+2% from 2000) of incident cases and 11% of (+2% from 2000) deaths among all PLC in young adults. About half of the countries showed an increase in the age-standardized incidence rate of alcohol-attributable PLC among young adults between 2000 and 2021. Conclusions: The incidence rate of alcohol-attributable liver cancer in young adults has shifted significantly over the past two decades, with notable increases in Europe and the Asia–Pacific region. This trend underscores the need for global strategies to address the rising prevalence of alcohol use disorder and alcohol-associated liver disease and their impact on young adults.
1

DDDisatorn Dejvajara
Disatorn Dejvajara
RARanlaphat Aungkasuraphan
Ranlaphat Aungkasuraphan
PPPiyathida Palee
Piyathida Palee
CPChanodom Piankusol
Chanodom Piankusol
Wachiranun SirikulWachiranun Sirikul
Wachiranun Sirikul
Penprapa SivirojPenprapa Siviroj
Penprapa Siviroj
The deterioration of muscle strength in aging has been associated with fall risks. During the COVID-19 pandemic, older adults were restricted from doing outdoor activities. This study aimed to investigate the effect of Nine-Square Step Exercises (NSSE) on improving physical performance and balance in older adults at risk of falling. We conducted an open-labelled, assessor-blinded, randomized controlled trial in 46 (aged 65–84 years) community-dwelling older adults. They were randomly assigned to an NSSE group (n = 24) instructed to perform the program for at least 45 days over 8 weeks or a control group (n = 22). The outcomes were measured by the Timed Up and Go Test (TUG), the Berg Balance Scale (BBS), the Five-Times-Sit-to-Stand test (FTSS), and hand grip strength during the baseline, 4th and 8th weeks in both groups. A mixed-effect linear regression model analysis was performed to estimate the independent effect of NSSE by the intention-to-treat over the 8-week period. The NSSE group showed significant weekly changes in BBS (β 0.57, 95% CI: 0.30, 0.84), TUG (β −0.44, 95% CI: −0.74, −0.14), and FTSS (β −0.52, 95% CI: −0.78, −0.25), demonstrating beneficial improvements in lower extremity and balance, whereas the control group did not demonstrate significant changes over time in any parameter.

14 January 2026 in Resuscitation Plus
Verified
Journal Article
Open access
TTThanat Tangpaisarn
Thanat Tangpaisarn
Wachira WongtanasarasinWachira Wongtanasarasin
Wachira Wongtanasarasin
MWMonthira Wangnongseaw
Monthira Wangnongseaw
CCChiratchaya Chinvanichai
Chiratchaya Chinvanichai
DDDisatorn Dejvajara
Disatorn Dejvajara
PPpariwat phungoen
pariwat phungoen
Emergency department cardiac arrest is increasingly recognized as a distinct entity, but little is known about its epidemiology in Asia. We compared patient characteristics, arrest etiologies, resuscitation processes, and outcomes between two tertiary university hospitals in Thailand. We conducted a retrospective cohort study of adults (≥18 years) with emergency department cardiac arrest at Chiang Mai University Hospital (January 2020–December 2024) and Khon Kaen University Hospital (November 2021–December 2024). Cases were identified using institutional electronic cardiac arrest registries. Data included demographics, comorbidities, presumed etiology (5H/5T framework), initial rhythm, resuscitation processes, and outcomes. Primary outcomes were return of spontaneous circulation, survival to hospital admission, and survival to discharge. A total of 261 cases were analyzed (192 from Chiang Mai University Hospital and 69 from Khon Kaen University Hospital). The median age was 65 years (interquartile range 53–75), and 56.7% were male. Most arrests were non-traumatic (72.8%), and pulseless electrical activity predominated (76.6%). Hypoxia (43.3%), acidosis (33.7%), and hypovolemia (31.0%) were the leading presumed causes. Institutional variation was observed in comorbidity profiles, presumed etiologies, ventilation strategies, and resuscitation durations. Median cardiopulmonary resuscitation duration was longer at Khon Kaen University Hospital (9 vs. 6 min). No statistically significant differences in survival outcomes were detected between hospitals. Emergency department cardiac arrest in Thailand mirrors global patterns, with a predominance of non-shockable rhythms and low discharge survival rates. Observed institutional variation in patient characteristics and resuscitation processes highlights the need for standardized protocols, training, and the development of national emergency department cardiac arrest registries to support quality improvement in low- and middle-income country settings.